Conjunctivitis in Adults with Atopic Dermatitis Treated with Dupilumab: An Observational Study of Clinical Characteristics, Symptomatology, and Treatment

Authors

Penny A. Asbell (ORCID: https://orcid.org/0000-0001-7583-7778)
Zhen Chen (ORCID: https://orcid.org/0000-0002-6289-4332)
Winston Chamberlain (ORCID: https://orcid.org/0000-0003-0007-9428)
Brad Shumel (ORCID: https://orcid.org/0000-0002-9285-8164)
Esen K. Akpek (ORCID: https://orcid.org/0000-0001-7700-207X)
Emma Lawless
Zafer E. Ozturk
Michael Van Spall

Institutions

Johns Hopkins University (US)
University of Tennessee Health Science Center (US)
Oregon Health & Science University (US)
Regeneron (United States) (US)
Johns Hopkins Medicine (US)
Sanofi (United States) (US)

Publication Details

Journal: Advances in Therapy
Published: 2025-05-19
DOI: https://doi.org/10.1007/s12325-025-03209-4
Citations: 3
Primary Topic: Dermatology and Skin Diseases
Type: article
Field-Weighted Citation Impact: 6.01

Funders

Sanofi
Regeneron Pharmaceuticals

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Conjunctivitis in Adults with Atopic Dermatitis Treated with Dupilumab: An Observational Study of Clinical Characteristics, Symptomatology, and Treatment

Penny A. Asbell, Zhen Chen, Winston Chamberlain, Brad Shumel et al.

May 19, 2025

3 citations

Advances in Therapy

Dermatology and Skin Diseases

6.01

article

Conjunctivitis in Adults with Atopic Dermatitis Treated with Dupilumab: An Observational Study of Clinical Characteristics, Symptomatology, and Treatment

Penny A. Asbell, Zhen Chen, Winston Chamberlain, Brad Shumel, Esen K. Akpek, Emma Lawless, Zafer E. Ozturk, Michael Van Spall

May 19, 2025article en

3 citations

Abstract

No abstract available for this paper.

Advances in TherapyVol. 42(7)

Johns Hopkins University (US), University of Tennessee Health Science Center (US), Oregon Health & Science University (US), Regeneron (United States) (US), Johns Hopkins Medicine (US), Sanofi (United States) (US)

Sanofi, Regeneron Pharmaceuticals

Openalex Percentile: Top 4%

Dermatology and Skin Diseases

6.01

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.